1993
DOI: 10.1002/ijc.2910540122
|View full text |Cite
|
Sign up to set email alerts
|

Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation

Abstract: We have investigated the effect of monoclonal antibodies (MAbs) specific for aminopeptidase N/CD13 on the invasion of human metastatic tumor cells into reconstituted basement membrane (Matrigel). The invasion of human metastatic tumor cells (SN12M renal-cell carcinoma, HT1080 fibrosarcoma and A375M melanoma) into Matrigel-coated filters was inhibited by an anti-CD13 MAb, WM15, in a concentration-dependent manner. However, this MAb did not have any effect on tumor-cell adhesion and migration to the extracellula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
231
3
1

Year Published

1996
1996
2014
2014

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 305 publications
(240 citation statements)
references
References 22 publications
(27 reference statements)
5
231
3
1
Order By: Relevance
“…Membrane type 1 matrix metalloproteinase (MT1-MMP) is expressed on endothelial tumor cells, including malignancies of lung; gastric, colon and cervical carcinomas; gliomas and melanomas (Danhier et al, 2010;Genís et al, 2006). Aminopeptidase N/CD13, a metalloproteinase that eliminates amino-acids from unblocked N-terminal segments of peptides or proteins, is an endothelial cell-surface receptor involved in tumorcell invasion, extracellular matrix degradation by tumor cells and tumor metastasis in vitro and in vivo (Saiki et al, 1993;Danhier et al, 2010). NGR (Asn-Gly-Arg) peptide is reported to bind to the aminopeptidase (Pasqualini et al, 2000;Danhier et al, 2010).…”
Section: Targeting Of Tumoral Endotheliummentioning
confidence: 99%
“…Membrane type 1 matrix metalloproteinase (MT1-MMP) is expressed on endothelial tumor cells, including malignancies of lung; gastric, colon and cervical carcinomas; gliomas and melanomas (Danhier et al, 2010;Genís et al, 2006). Aminopeptidase N/CD13, a metalloproteinase that eliminates amino-acids from unblocked N-terminal segments of peptides or proteins, is an endothelial cell-surface receptor involved in tumorcell invasion, extracellular matrix degradation by tumor cells and tumor metastasis in vitro and in vivo (Saiki et al, 1993;Danhier et al, 2010). NGR (Asn-Gly-Arg) peptide is reported to bind to the aminopeptidase (Pasqualini et al, 2000;Danhier et al, 2010).…”
Section: Targeting Of Tumoral Endotheliummentioning
confidence: 99%
“…Chemoinvasion assay was carried out by the method of Saiki et al (22). The lower and upper sides of 8 μm porosity polycarbonate filters were coated with 0.5 mg/ml type I collagen and 0.5 mg/ml Matrigel, respectively.…”
Section: Reverse Transcription-polymerase Chain Reaction (Rt-pcr)mentioning
confidence: 99%
“…Increased expression of NEP in hepatocellular carcinoma has also been reported to be correlated with malignant transformation (Dragovic et al, 1994). Similarly, over-expression of APN/CD13 was directly involved in tumor invasion of renal cell cancer and melanoma (Fujii et al, 1995;Saiki et al, 1993) or in tumor proliferation of choriocarcinoma (Ino et al, 1994). Our recent studies have shown the upregulated expression of APA in choriocarcinoma and invasive cervical cancer (Fujimura et al, 2000).…”
Section: Ino Et Almentioning
confidence: 85%